The Viruses That Never Leave
Most infections follow a familiar arc: the pathogen enters, the immune system mounts a response, and after days or weeks, the illness resolves and the virus is cleared. But a distinct class of viruses behaves very differently. Once established in the human body, they persist — sometimes dormant for decades, sometimes detectable throughout life, sometimes reemerging at moments of immune suppression to cause new damage. Understanding what drives viral load variation in these persistent infections has been a longstanding challenge in biomedical research.
A study published this week in the journal Nature has produced the largest systematic analysis of human persistent viral loads ever conducted. Researchers from Harvard Medical School, Brigham and Women's Hospital, and the Broad Institute analyzed data from more than 900,000 individuals across three major biobanks — the UK Biobank, the NIH All of Us Research Program, and the Simons Foundation's SPARK autism research dataset.
The Seven Viruses Under the Microscope
The study focused on seven DNA viruses known to persist in the human body: Epstein-Barr virus, HHV-6, HHV-7, Merkel cell polyomavirus, and three types of anelloviruses. The anelloviruses are among the most ubiquitous human viruses ever identified — present in roughly 90% of the global population, yet most people have never heard of them and they produce no known symptoms. Their near-universal presence makes them a powerful tool for studying host-virus dynamics in a large, diverse population.
The research team measured viral DNA levels in blood and saliva samples, then cross-referenced these measurements against a vast array of host variables: age, sex, smoking status, season of sample collection, and hundreds of genetic variants identified through genome-wide association analysis.
Age, Sex, and Seasons Shape Viral Behavior
The findings revealed that persistent viruses are far from static. Epstein-Barr viral load increases consistently with age, suggesting that the immune system's declining efficiency in later life allows a virus that was previously suppressed to gradually reassert itself. In contrast, HHV-6 and HHV-7 loads decrease after childhood — a pattern consistent with the immune system establishing durable control after initial infection early in life.
Seasonal variation also emerged as a significant factor. Epstein-Barr levels rise in winter and fall in summer; HHV-7 shows precisely the opposite pattern. The biological mechanisms behind these cycles remain to be fully elucidated, but the regularity of the seasonal signal across hundreds of thousands of individuals suggests a real and reproducible phenomenon. Men showed consistently higher viral loads than women across all seven viruses studied.
Smoking Nearly Doubles Epstein-Barr Viral Load
One of the most clinically significant findings is the relationship between heavy smoking and Epstein-Barr viral load. The study found that heavy smokers had nearly twice the Epstein-Barr load of non-smokers. Given that Epstein-Barr virus is associated with multiple serious health conditions — including certain lymphomas and, through a distinct mechanism, multiple sclerosis — this result suggests a possible pathway by which smoking contributes to elevated disease risk beyond its well-established effects on respiratory and cardiovascular health.
Genetics, Disease Risk, and What Comes Next
The genome-wide component of the study identified dozens of genetic variants associated with viral load differences across the seven viruses. Nearly all of these variants are located in or near genes involved in immune system function, confirming that individual variation in immune response is a major driver of why some people carry higher or lower viral burdens over a lifetime.
The disease implications are particularly striking for Epstein-Barr. The study found that immune responses to the virus — rather than lifetime viral load — increase multiple sclerosis risk, consistent with the hypothesis that MS results partly from immune cross-reactivity triggered by EBV. High Epstein-Barr viral load was separately identified as a causal risk factor for Hodgkin lymphoma, a finding that the researchers flag for further investigation.
Lead researcher Nolan Kamitaki of Harvard Medical School framed the broader significance: we are getting to the point where we can use human genetics to answer fundamental questions about pathology resulting from viruses. At the scale of 900,000 individuals, the study offers a foundation for understanding persistent viral infections not just as biological curiosities but as modifiable factors in long-term disease risk — factors that could, in principle, become targets for intervention as the mechanisms are better understood.
This article is based on reporting by Medical Xpress. Read the original article.
